ATLANTA, May 16, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of inoffice, accessible, and innovative therapeutic and diagnostic products, announces CEO and Founder Kathy LeeSepsick met with the White House's Gender Policy Council (GPC) staff to discuss the Company's reproductive health products and the future of women's health in the United States. According to The White House, "The ...